{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:54:08Z","timestamp":1791849248705,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K19409"],"award-info":[{"award-number":["23K19409"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01445-1","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:44:47Z","timestamp":1782330287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Morbidity, mortality, facility placement and cost of deep brain stimulation for Parkinson\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Hikaru","family":"Kamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas R.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Remz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael M.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianne","family":"Smiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Okun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"1445_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"1445_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11065-022-09540-9","volume":"33","author":"M Bucur","year":"2023","unstructured":"Bucur, M. & Papagno, C. Deep brain stimulation in Parkinson's disease: a meta-analysis of the long-term neuropsychological outcomes. Neuropsychol. Rev. 33, 307\u2013346 (2023).","journal-title":"Neuropsychol. Rev."},{"key":"1445_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.813387","volume":"16","author":"JK Wong","year":"2022","unstructured":"Wong, J. K. et al. Proceedings of the ninth annual deep brain stimulation think tank: advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, pain, interventional psychiatry, epilepsy, and traumatic brain injury. Front. Hum. Neurosci. 16, 813387 (2022).","journal-title":"Front. Hum. Neurosci."},{"key":"1445_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000550490","volume":"19","author":"H Kamo","year":"2026","unstructured":"Kamo, H. et al. Long-term mortality and 10-year outcomes after subthalamic nucleus deep brain stimulation in Parkinson\u2019s disease. Stereotact. Funct. Neurosurg 19, 1\u201311 (2026).","journal-title":"Stereotact. Funct. Neurosurg"},{"key":"1445_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2021.684895","volume":"15","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Deep brain stimulation complications in patients with Parkinson\u2019s disease and surgical modifications: a single-center retrospective analysis. Front. Hum. Neurosci. 15, 684895 (2021).","journal-title":"Front. Hum. Neurosci."},{"key":"1445_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1227\/ons.0000000000001323","volume":"28","author":"J Tiefenbach","year":"2025","unstructured":"Tiefenbach, J. et al. The rate and risk factors of deep brain stimulation-associated complications: a single-center experience. Oper. Neurosurg. 28, 519\u2013527 (2025).","journal-title":"Oper. Neurosurg."},{"key":"1445_CR7","doi-asserted-by":"publisher","unstructured":"Meyer, G. M. et al. Deep brain stimulation and psychosis: a case series and two candidate causal brain circuits. medRxiv https:\/\/doi.org\/10.1101\/2025.11.18.25340443 (2025).","DOI":"10.1101\/2025.11.18.25340443"},{"key":"1445_CR8","doi-asserted-by":"publisher","unstructured":"Kamo, H. et al. Motor and cognitive outcome after subthalamic nucleus deep brain stimulation in patients with Parkinson\u2019s disease harboring GBA1 variant. Mov. Disord. Clin. Pract. 13, https:\/\/doi.org\/10.1002\/mdc3.70411 (2025).","DOI":"10.1002\/mdc3.70411"},{"key":"1445_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1017\/cjn.2020.187","volume":"48","author":"JAG Crispo","year":"2021","unstructured":"Crispo, J. A. G. et al. Survival and health care use after deep brain stimulation for Parkinson\u2019s disease. Can. J. Neurol. Sci. 48, 372\u2013382 (2021).","journal-title":"Can. J. Neurol. Sci."},{"key":"1445_CR10","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e10","volume":"38","author":"A Kim","year":"2023","unstructured":"Kim, A. et al. Mortality of deep brain stimulation and risk factors in patients with Parkinson\u2019s disease: a national cohort study in Korea. J. Korean Med. Sci. 38, e10 (2023).","journal-title":"J. Korean Med. Sci."},{"key":"1445_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.parkreldis.2019.11.023","volume":"70","author":"RB Schneider","year":"2020","unstructured":"Schneider, R. B. et al. Acute readmission following deep brain stimulation surgery for Parkinson\u2019s disease: a nationwide analysis. Park. Relat. Disord. 70, 96\u2013102 (2020).","journal-title":"Park. Relat. Disord."},{"key":"1445_CR12","doi-asserted-by":"publisher","unstructured":"Starr P. A. et al. Five-year outcomes from deep brain stimulation of the subthalamic nucleus for Parkinson's disease. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2025.3373 (2025).","DOI":"10.1001\/jamaneurol.2025.3373"},{"key":"1445_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00415-025-12915-6","volume":"272","author":"R Reese","year":"2025","unstructured":"Reese, R. et al. Invasive therapies for Parkinson\u2019s disease: an adapted excerpt from the guidelines of the German Society of Neurology. J. Neurol. 272, 219 (2025).","journal-title":"J. Neurol."},{"key":"1445_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/padi\/5157873","volume":"2024","author":"M Huhn","year":"2024","unstructured":"Huhn, M., Prewett, M., Rossignol, J. & Dunbar, G. L. Comparison of the long-term efficacy of targeting the subthalamic nucleus versus the globus pallidus interna for deep brain stimulation treatment of motor dysfunction in patients with Parkinson\u2019s disease: a meta-analysis study. Parkinsons Dis. 2024, 5157873 (2024).","journal-title":"Parkinsons Dis."},{"key":"1445_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jdbs.2023.03.002","volume":"1","author":"A Umemura","year":"2023","unstructured":"Umemura, A. et al. Application of current steering with MICC directional lead in STN-DBS for Parkinson\u2019s disease. Deep Brain Stimul. 1, 20\u201325 (2023).","journal-title":"Deep Brain Stimul."},{"key":"1445_CR16","doi-asserted-by":"publisher","unstructured":"Kamo, H. et al. Finely tuned gamma oscillations in the globus pallidus internus in Parkinson\u2019s disease. Mov. Disord. Clin. Pract. https:\/\/doi.org\/10.1002\/mdc3.70251 (2025).","DOI":"10.1002\/mdc3.70251"},{"key":"1445_CR17","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.brs.2021.10.041","volume":"14","author":"G Oyama","year":"2021","unstructured":"Oyama, G. et al. Adaptive deep brain stimulation in real world: First observational data from the Japanese Early Adapter studies on adaptive deep brain stimulation (aDBS). Brain Stimul. 14, 1600\u20131601 (2021).","journal-title":"Brain Stimul."},{"key":"1445_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2008.929","volume":"301","author":"FM Weaver","year":"2009","unstructured":"Weaver, F. M. et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. Jama 301, 63\u201373 (2009).","journal-title":"Jama"},{"key":"1445_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/jamaneurol.2017.3976","volume":"75","author":"MS Okun","year":"2018","unstructured":"Okun, M. S., Ramirez-Zamora, A. & Foote, K. D. Neuromedicine service and science hub model. JAMA Neurol. 75, 271\u2013272 (2018).","journal-title":"JAMA Neurol."},{"key":"1445_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/jnnp-2024-333947","volume":"96","author":"V Hvingelby","year":"2025","unstructured":"Hvingelby, V. et al. Directional deep brain stimulation electrodes in Parkinson\u2019s disease: meta-analysis and systematic review of the literature. J. Neurol. Neurosurg. Psychiatry 96, 188\u2013198 (2025).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1445_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2021.667035","volume":"15","author":"A Mahajan","year":"2021","unstructured":"Mahajan, A., Butala, A., Okun, M. S., Mari, Z. & Mills, K. A. Global variability in deep brain stimulation practices for Parkinson\u2019s disease. Front Hum. Neurosci. 15, 667035 (2021).","journal-title":"Front Hum. Neurosci."},{"key":"1445_CR22","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1212\/WNL.0000000000009946","volume":"95","author":"ML Hacker","year":"2020","unstructured":"Hacker, M. L. et al. Deep brain stimulation in early-stage Parkinson disease: five-year outcomes. Neurology 95, e393\u2013e401 (2020).","journal-title":"Neurology"},{"key":"1445_CR23","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/mds.29052","volume":"37","author":"P Mahlknecht","year":"2022","unstructured":"Mahlknecht, P., Foltynie, T., Limousin, P. & Poewe, W. How does deep brain stimulation change the course of Parkinson\u2019s disease? Mov. Disord. 37, 1581\u20131592 (2022).","journal-title":"Mov. Disord."},{"key":"1445_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49511-5","volume":"13","author":"D Guehl","year":"2023","unstructured":"Guehl, D. et al. Usefulness of thalamic beta activity for closed-loop therapy in essential tremor. Sci. Rep. 13, 22332 (2023).","journal-title":"Sci. Rep."},{"key":"1445_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2024.100366","volume":"79","author":"T de la Rosa","year":"2024","unstructured":"de la Rosa, T. & Scorza, F. A. Parkinson\u2019s disease inpatient mortality: attention to sudden death. Clinics 79, 100366 (2024).","journal-title":"Clinics"},{"key":"1445_CR26","doi-asserted-by":"publisher","first-page":"e001464","DOI":"10.1136\/bmjno-2025-001464","volume":"8","author":"S Aungsumart","year":"2026","unstructured":"Aungsumart, S. et al. Deep brain stimulation for Parkinson\u2019s disease in Thailand: cost, utility and policy implications for universal health coverage. BMJ Neurol. Open 8, e001464 (2026).","journal-title":"BMJ Neurol. Open"},{"key":"1445_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2026.1735033","volume":"14","author":"M Sensi","year":"2026","unstructured":"Sensi, M. et al. Budget impact analysis of deep brain stimulation devices with different longevity in Parkinson\u2019s disease: insights from real-world data. Front. Public Health 14, 1735033 (2026).","journal-title":"Front. Public Health"},{"key":"1445_CR28","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00702-016-1562-1","volume":"123","author":"C van Riesen","year":"2016","unstructured":"van Riesen, C. et al. Disease-specific longevity of impulse generators in deep brain stimulation and review of the literature. J. Neural Transm. 123, 621\u2013630 (2016).","journal-title":"J. Neural Transm."},{"key":"1445_CR29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.5603\/PJNNS.a2021.0041","volume":"55","author":"F Przytu\u0142a","year":"2021","unstructured":"Przytu\u0142a, F., Dulski, J., Sobstyl, M. & S\u0142awek, J. Battery for deep brain stimulation depletion in Parkinson\u2019s Disease and dystonia patients - a systematic review. Neurol. Neurochir. Pol. 55, 346\u2013350 (2021).","journal-title":"Neurol. Neurochir. Pol."},{"key":"1445_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000538748","volume":"102","author":"AE Bishay","year":"2024","unstructured":"Bishay, A. E. et al. Disparities in access to deep brain stimulation for Parkinson\u2019s disease and proposed interventions: a literature review. Stereotact. Funct. Neurosurg. 102, 179\u2013194 (2024).","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"1445_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2023.1269401","volume":"17","author":"AA Memon","year":"2023","unstructured":"Memon, A. A. et al. A systematic review of health disparities research in deep brain stimulation surgery for Parkinson\u2019s disease. Front. Hum. Neurosci. 17, 1269401 (2023).","journal-title":"Front. Hum. Neurosci."},{"key":"1445_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41531-022-00305-y","volume":"8","author":"ST Jost","year":"2022","unstructured":"Jost, S. T. et al. Gender gap in deep brain stimulation for Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 47 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1445_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1233684","volume":"14","author":"M Frassica","year":"2023","unstructured":"Frassica, M. et al. Racial disparities in access to DBS: results of a real-world U.S. claims data analysis. Front. Neurol. 14, 1233684 (2023).","journal-title":"Front. Neurol."},{"key":"1445_CR34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/mdc3.70312","volume":"13","author":"F Ba","year":"2025","unstructured":"Ba, F. et al. Ethnic and gender disparities in access to deep brain stimulation surgery for Parkinson\u2019s disease. Mov. Disord. Clin. Pract 13, 430\u2013441 (2025).","journal-title":"Mov. Disord. Clin. Pract"},{"key":"1445_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.830196","volume":"13","author":"D Falconer","year":"2022","unstructured":"Falconer, D., Gow, S., Whitney, D., Walters, H. & Rogers, S. The power of access in Parkinson\u2019s disease care: a retrospective review of telehealth uptake during the COVID-19 pandemic. Front. Neurol. 13, 830196 (2022).","journal-title":"Front. Neurol."},{"key":"1445_CR36","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3171\/jns.2003.99.5.0863","volume":"99","author":"EN Eskandar","year":"2003","unstructured":"Eskandar, E. N., Flaherty, A., Cosgrove, G. R., Shinobu, L. A. & Barker, F. G. 2nd. Surgery for Parkinson disease in the United States, 1996 to 2000: practice patterns, short-term outcomes, and hospital charges in a nationwide sample. J. Neurosurg. 99, 863\u2013871 (2003).","journal-title":"J. Neurosurg."},{"key":"1445_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/anae.15617","volume":"77","author":"RLH Yim","year":"2022","unstructured":"Yim, R. L. H., Leung, K. M. M., Poon, C. C. M. & Irwin, M. G. Peri-operative management of patients with Parkinson\u2019s disease. Anaesthesia 77, 123\u2013133 (2022).","journal-title":"Anaesthesia"},{"key":"1445_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.parkreldis.2021.07.001","volume":"89","author":"VD Sharma","year":"2021","unstructured":"Sharma, V. D. et al. Telemedicine and deep brain stimulation - current practices and recommendations. Park. Relat. Disord. 89, 199\u2013205 (2021).","journal-title":"Park. Relat. Disord."},{"key":"1445_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.parkreldis.2022.04.018","volume":"99","author":"M Ogawa","year":"2022","unstructured":"Ogawa, M. et al. Can AI make people happy? The effect of AI-based chatbot on smile and speech in Parkinson\u2019s disease. Park. Relat. Disord. 99, 43\u201346 (2022).","journal-title":"Park. Relat. Disord."},{"key":"1445_CR40","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/WCO.0000000000001377","volume":"38","author":"J Cavaleri","year":"2025","unstructured":"Cavaleri, J., Stefanescu, K., Lee, D. & Mason, X. Deep brain stimulation access in 2025: geographic, gender, racial, and socioeconomic disparities re-examined. Curr. Opin. Neurol. 38, 330\u2013336 (2025).","journal-title":"Curr. Opin. Neurol."},{"key":"1445_CR41","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/ana.26378","volume":"92","author":"SW Cramer","year":"2022","unstructured":"Cramer, S. W. et al. Persistent racial disparities in deep brain stimulation for Parkinson\u2019s disease. Ann. Neurol. 92, 246\u2013254 (2022).","journal-title":"Ann. Neurol."},{"key":"1445_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/B978-0-444-53497-2.00009-7","volume":"116","author":"P Pollak","year":"2013","unstructured":"Pollak, P. Deep brain stimulation for Parkinson\u2019s disease - patient selection. Handb. Clin. Neurol. 116, 97\u2013105 (2013).","journal-title":"Handb. Clin. Neurol."},{"key":"1445_CR43","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/j.wneu.2018.09.035","volume":"121","author":"A Razmkon","year":"2019","unstructured":"Razmkon, A. et al. Initial results of bilateral subthalamic nucleus stimulation for Parkinson's disease in a newly established center in a developing country: Shiraz, Southern Iran. World Neurosurg. 121, e129\u2013e135 (2019).","journal-title":"World Neurosurg."},{"key":"1445_CR44","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/mdc3.12103","volume":"1","author":"RR Coleman","year":"2014","unstructured":"Coleman, R. R., Kotagal, V., Patil, P. G. & Chou, K. L. Validity and efficacy of screening algorithms for assessing deep brain stimulation candidacy in Parkinson disease. Mov. Disord. Clin. Pract. 1, 342\u2013347 (2014).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1445_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41531-025-00974-5","volume":"11","author":"M Guidetti","year":"2025","unstructured":"Guidetti, M. et al. Will adaptive deep brain stimulation for Parkinson\u2019s disease become a real option soon? A Delphi consensus study. NPJ Parkinsons Dis. 11, 110 (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"1445_CR46","doi-asserted-by":"publisher","unstructured":"Li, Q. et al. Adaptive vs conventional deep brain stimulation of the subthalamic nucleus for treatment of Parkinson\u2019s disease: a multicenter retrospective study. Neuromodulation https:\/\/doi.org\/10.1016\/j.neurom.2025.04.011 (2025).","DOI":"10.1016\/j.neurom.2025.04.011"},{"key":"1445_CR47","doi-asserted-by":"publisher","unstructured":"Bronte-Stewart, H. M. et al. Long-term personalized adaptive deep brain stimulation in Parkinson's disease: a nonrandomized clinical trial. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2025.2781 (2025).","DOI":"10.1001\/jamaneurol.2025.2781"},{"key":"1445_CR48","doi-asserted-by":"publisher","unstructured":"Kamo, H. et al. Contrasting effects of deep brain stimulation and intravenous levodopa on local field potentials. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.70196 (2026).","DOI":"10.1002\/mds.70196"},{"key":"1445_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2026.108217","volume":"144","author":"H Kamo","year":"2026","unstructured":"Kamo, H. et al. Five-year risk of cardiovascular events and falling in Parkinson\u2019s disease with orthostatic hypotension: A nationwide cohort study. Park. Relat. Disord. 144, 108217 (2026).","journal-title":"Park. Relat. Disord."},{"key":"1445_CR50","doi-asserted-by":"publisher","unstructured":"Kamo H. et al. Urinary tract infections in hospitalized patients with Parkinson\u2019s disease: risk factors and outcomes. Mov. Disord. Clin. Pract. https:\/\/doi.org\/10.1002\/mdc3.70556 (2026).","DOI":"10.1002\/mdc3.70556"},{"key":"1445_CR51","doi-asserted-by":"publisher","unstructured":"Kamo, H. et al. Machine learning prediction of discharge destination in patients with Parkinson\u2019s disease; a nationwide cohort study. Res. Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-8399223\/v1 (2026).","DOI":"10.21203\/rs.3.rs-8399223\/v1"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01445-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01445-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01445-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:22:42Z","timestamp":1791847362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01445-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1445"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01445-1","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.K. received grant support from the Japanese Society of Neurology and the Melvin Yahr Clinical Research Award from the IAPRD\/Parkinson\u2019s Foundation, unrelated to the present study. R.M.B.: None. T.R.M.: None. M.R.: None. A.B.: Employment (Parkinson\u2019s Foundation). A.S.: Employment (Parkinson\u2019s Foundation). M.S.O.: Okun serves as Medical Advisor to the Parkinson\u2019s Foundation and has received research grants from the NIH, Parkinson\u2019s Foundation, the Michael J. Fox Foundation, the Parkinson Alliance, the Smallwood Foundation, the Tourette Association of America, and the UF Foundation. Dr. Okun\u2019s research is supported by NIH awards R01NS131342, R01NR014852, R01NS096008, UH3NS119844, and U01NS119562; he is a multi-PI of the NIH R25NS108939 training grant. Okun has received royalties for publications with Hachette Book Group, Demos, Manson, Amazon, Smashwords, Books4Patients, Perseus, Robert Rose, Oxford, and Cambridge (movement disorders books). He is an Associate Editor for NEJM Journal Watch Neurology and JAMA Neurology. Okun has participated in CME and educational activities (past 12\u201324 months) on movement disorders sponsored by WebMD\/Medscape, RMEI Medical Education, the American Academy of Neurology, the International Parkinson and Movement Disorder Society, Mediflix, and Vanderbilt University. The institution, and not Okun, receives grants from industry. He has participated as site PI and\/or co-I in several NIH, foundation, and industry-sponsored trials without receiving honoraria. Research projects at the University of Florida receive device and drug donations. C.W.H.: C.W.H. has served as an Independent Safety Advisor for Saluda Medical and has received research funding from the Parkinson\u2019s Foundation and honoraria for speaking engagements, grant reviews, and scientific reviews from The Parkinson\u2019s Foundation, World Parkinson Congress, and UpToDate. C.W.H.: CWH has served as an Independent Safety Advisor for Saluda Medical and has received research funding from the Parkinson\u2019s Foundation and honoraria for speaking engagements, grant reviews, and scientific reviews from The Parkinson\u2019s Foundation, World Parkinson Congress, and UpToDate.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"248"}}